Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral methylnaltrexone for prevention of postoperative opioid-induced constipation after elective orthopaedic surgery
2004-004496-10Phase 2Completed
- Sponsor
- Norgine
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylnaltrexone in opioid-induced constipation (OIC) (3 arms), sponsored by Norgine. Primary endpoints: Time to first stool post-operatively and Faecal water content. Started Mar 2005; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2004-004496-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004496-10.